期刊文献+

组织芯片法检测胃癌组织中HIF-1α和DEC1的表达及其意义

Expressions and clinical significances of HIF-1α and DEC1 in tissues array of gastric carcinoma
下载PDF
导出
摘要 目的研究胃癌组织中HIF-1α和DEC1的表达情况及其意义。方法应用组织芯片方法检测162例胃癌组织和32例癌旁组织中HIF-1α和DEC1蛋白的表达。结果 HIF-1α在胃癌组织和癌旁组织中表达的阳性率分别为37.04%(60/162)和9.38%(3/32),两者差异有统计学意义(P<0.05);HIF-1α的表达与肿瘤分期、浸润深度和淋巴结转移有关(P<0.05)。DEC1在胃癌组织及癌旁组织中表达的阳性率分别为11.11%和3.13%,两者之间差异无统计学意义(P>0.05)。结论 HIF-1α在胃癌组织中高表达,与胃癌的发生、发展及转移密切相关;而DEC1在胃癌组织中低表达,其临床价值尚有待于进一步研究。 【Objective】 To investigate the expressions of HIF-1α and DEC1 in gastric carcinoma.【Methods】 The TMA technology was used to detect the expression of HIF-1α and DEC1 in 162 gastric carcinoma(GC) and 32 para-carcinoma.【Results】 The positive expression rates of HIF-1α in gastric carcinoma and in paired para-carcinoma were 37.04%(60/162),9.38%(3/32) respectively(P 0.05).The expression of HIF-1α was significantly associated with TNM stage,the depth of invasion and lymph node metastasis(P 0.05).The positive expression rates of DEC1 in gastric carcinoma and in paired para-carcinoma were 11.11%(18/162),3.13%(1/32) respectively(P 0.05).【Conclusions】 HIF-1α was over-expressed in gastric carcinoma,and was correlated with the oncogenesis,development and metastasis of gastric carcinoma.The expression of DEC1 in gastric carcinoma was lower,and its clinical vanue needs to be studied further.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第23期72-75,共4页 China Journal of Modern Medicine
关键词 组织芯片 免疫组织化学 胃癌 HIF-1Α DEC1 tissue microarrays immunohistochemistry gastric cancer Hypoxia-inducible factor 1 Alpha differentiated embryo-chondrocyte expressed gene 1
  • 相关文献

参考文献14

  • 1LEE BL, KIM WH, JUNG J, et al. A hypoxia-independent up-regulatlon of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer[J]. Carcinogenesis, 2008, 29(1): 44-51.
  • 2CHAKRABARTI J, TURLEY H, CAMPO L. et al. The transcription factor DEC1 (stral3, SHARP2) is associated with the hypoxic response and high turnout grade in human breast can-eers[J]. British Journal of Cancer, 2004, 91(5): 954-958.
  • 3WOELFLE U, CLOOS J, SAUTER G, et al. Molecular signature associated with bone marrow micro-metastasis in human breast cancer[J]. Cancer Res, 2003, 63(18): 5679-5684.
  • 4FILLIES T, WERKMEISTER R, VAN DIEST PJ, et al. HIFl-alpha overexpression indicates a good prognosis in early stage squamous call carcinomas of the oral floor[J]. BMC Cancer, 2005, 5(1): 84-92.
  • 5CABUK D, BASARAN G, CELIKEL C, et al. Vascular endothelial growth factor, hypoxia-inducible factor l alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival[J]. Oncology, 2007. 72(1-2): 111-117.
  • 6ZHONG H, DE MARZO AM, LAUGHNER E, et al. Overexpression of hypoxia-inducible factor 1 a in common human cancers and their metastases[J]. Cancer Res, 1999, 59(22): 5830-5835.
  • 7OH SY, KWON HC, KIM SH. Clinicopathologic significance of HIF-I α, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer[J]. BMC Cancer, 2008, 8(1): 123- 129.
  • 8HORREE N, DIEST PJ, VAN DER GROEP P, et al. Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis [J]. Cell Oncol, 2007, 29(3): 219-227.
  • 9MIZOKAMI K, KAKEJI Y, ODA S, et al. Clinicopathologic sig-nificance of hypoxia-inducible factor 1 ot overexpression in gas- tric carcinomas[J]. J Surg Oncol, 2006, 94(2): 149-154.
  • 10GRAEBER TG, OSMANIAN C, JACKS T, et al. Hypoxia-me- diated selection of cells with diminished apoptotic potential in solid tumors[J]. Nature, 1996, 379(6560): 88-91.

二级参考文献12

  • 1Ivanova A V, Ivanov S V, Danilkovitch-Miagkova A, et al. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway [J]. J Biol Chem, 2001, 276(18):15306-15315.
  • 2Qian Y J, Zhang J, Yah B F, et al. DEC1, a Basic Helix-Loop-Helix Transcription Factor and a Novel Target Gene of the p53 Family, Mediates p53-dependent Premature Senescence [J]. J Biol Chem, 2008,283 (5) :2896-2905.
  • 3Ivanova AV, Ivanov SV, Zhang X, et al. STRAI3 Interacts with STAT3 and Modulates Transcription of STAT3-dependent Targets[J]. J Mol Biol, 2004,340(4):641-653.
  • 4Guillaumond F, Lacoche S, Dulong S, et al. Altered Stra13 and Dec'2 circadian gene expression in hypoxie cells [J]. Bioehem Biophys Res Commun, 2008,369(4):1184-1189.
  • 5St-Pierre B, Flock G, Zacksenhaus E, et al. Stral3 Homodimers Repress Transcription through Class BE-box Elements [J]. J Biol Chem, 2002,277 (48) :46544-46551.
  • 6Chakrabarti J, Turley H, Campo L, et al. The transcription factor DEC1 (stral3, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers[J]. British Journal of Cancer, 2004,91 (5):954-958.
  • 7Li YX, Zhang H, Xie MX, et al. Abundant expression of Decl/ stra13/sharp2 in colon carcinoma:its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation [J]. Biochem J, 2002,367 (Pt 2):413-422.
  • 8Gong WD, Wang LW, Yao JC, et al. Expression of activated signal transdueer transcription 3 predicts expression endothelial growth factor in and phenotype of human gastric cancer [J]. Clin Cancer Res, 2005,11 (4):1386-1393.
  • 9Kanda N, Seno H, Konda Y, et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells[J]. Oncogene, 2004,23(28):4921-4929.
  • 10Kim DY, Cha ST, Ahn DH, et al. STAT3 expression in gastric cancer indicates a poor prognosis[J]. J Gastroenterol Hepatol, 2008,24 (4):646-651.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部